Tag Archives: Cancer

Exome Analysis with Ion AmpliSeq and Ingenuity Variant Analysis

Cancer genomics represents one of the most active and exciting areas of clinical research.  Particularly important is the work being done to generate genetic signatures for cancers, an advance that will enable better risk assessment and treatment decision making. Ion … Read More

Posted in Ingenuity Variant Analysis | Tagged , ,

Free Webinar: Using RNA-Seq to Study Breast Cancers

On September 26, Ingenuity is sponsoring a free webinar hosted by The Scientist magazine. Presenting will be Dr. Milan Radovich, assistant professor in the Department of Surgery at the Indiana University School of Medicine, who will discuss study data from … Read More

Posted in Events, IPA, News | Tagged , , , , , , , , ,

Still Time to Submit a Grant Application…It’s Easy!

Ingenuity Systems Fall Grant program is quickly coming to the submission deadline – Friday, August 23rd! If your work involves cancer, infectious or rare disease, drug response, or genome interpretation, this may be the perfect opportunity for you. We adjusted … Read More

Posted in Ingenuity Variant Analysis, IPA | Tagged , , , , , , , ,

NCI Cancer Data Underscores Need for Shared Downstream Analytics

Last week’s announcement that the National Cancer Institute had released the world’s largest cancer data set and made the information publicly available via Ingenuity and other databases was newsworthy enough to get attention from mainstream media, including NPR, Bloomberg, and … Read More

Posted in News | Tagged , , , , , , , , , , ,

Data Sharing and Publishing in Variant Analysis

Data sharing is a critical component of any research project and something that we’ve thought a lot about at Ingenuity. What is often an overlooked feature of analysis tools has inspired us to create two must-have features: Share and Publish. … Read More

Posted in Customer Success Stories, Ingenuity Variant Analysis, News, Oncology, Publications, Rare inherited diseases, Videos | Tagged , , , , , , , , , , ,